Top compounds associated with response to ARMCX5


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0072 0.8
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA Crizotinib gCSI pan-cancer AAC 0.013 0.8
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0076 0.8
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC -0.026 0.8
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.0071 0.8
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.015 0.8
mRNA rigosertib CTRPv2 pan-cancer AAC 0.0064 0.8
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.007 0.9
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.007 0.9
Download CSV